A recent study has found that targeting synaptic vesicle protein 2A in two transgenic Alzheimer’s disease mouse models (APP/PS1 and 3xTg-AD) can have a therapeutic effect on memory impairment.
A recent study has found that targeting synaptic vesicle protein 2A in two transgenic Alzheimer’s disease mouse models (APP/PS1 and 3xTg-AD) can have a therapeutic effect on memory impairment.
A new treatment approach administers medication deep within the brain through an electronic micropump to target the specific cells that cause seizures.
A new treatment approach administers medication deep within the brain through an electronic micropump to target the specific cells that cause seizures.
Despite the fact that over 8,400 patients die per year from oral cavity and pharynx cancers—most of whom are over the age of 65—the costs associated with these illnesses are not well understood.
Despite the fact that over 8,400 patients die per year from oral cavity and pharynx cancers—most of whom are over the age of 65—the costs associated with these illnesses are not well understood.
The FDA approved the Brio Neurostimulation System, a deep brain stimulation device implanted under the skin of the upper chest with electrodes attaching to the brain, to mitigate symptoms of Parkinson’s disease or essential tremor.
The FDA approved the Brio Neurostimulation System, a deep brain stimulation device implanted under the skin of the upper chest with electrodes attaching to the brain, to mitigate symptoms of Parkinson’s disease or essential tremor.